BioTelemetry Company Profile (NASDAQ:BEAT)

Analyst Ratings

Consensus Ratings for BioTelemetry (NASDAQ:BEAT) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $20.00 (15.34% upside)

Analysts' Ratings History for BioTelemetry (NASDAQ:BEAT)
Show:
DateFirmActionRatingPrice TargetActions
7/28/2015Dougherty & CoBoost Price TargetBuy$18.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/24/2014Avondale PartnersUpgradeMarket Perform -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/26/2014 forward)

Earnings

Earnings History for BioTelemetry (NASDAQ:BEAT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/4/2016        
4/26/2016Q1$0.10$0.20$46.54 million$48.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/17/2016Q415$0.11$0.15$45.89 million$46.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/9/2015Q3$0.11$0.13$46.05 million$43.49 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2015Q2$0.09$0.12$45.75 million$44.81 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2015Q115$0.02$0.06$43.80 million$43.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/19/2015Q414$0.06$0.05$43.40 million$43.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2014Q214$0.02$0.06$42.00 million$43.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/31/2014Q114$0.01$0.02$40.95 million$42.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2014Q413($0.02)($0.04)$38.40 million$37.16 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2014Q313($0.04)$0.05$32.26 million$33.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2013($0.05)($0.12)$32.79 million$31.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2013Q2 2013$0.02$27.50 million$32.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/13/2013Q4 2012($0.09)$26.80 million$30.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2012Q312($0.09)($0.08)$26.49 million$27.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/8/2012($0.04)($0.01)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2012($0.12)($0.10)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/22/2012($0.13)($0.04)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/8/2011($0.09)($0.21)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/8/2011($0.06)($0.05)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/3/2011($0.15)($0.02)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/17/2011($0.16)($0.13)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for BioTelemetry (NASDAQ:BEAT)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$0.08$0.09$0.09
Q2 20161$0.16$0.16$0.16
Q3 20162$0.14$0.16$0.15
Q4 20161$0.16$0.16$0.16
Q1 20171$0.17$0.17$0.17
Q2 20171$0.18$0.18$0.18
Q3 20171$0.18$0.18$0.18
Q4 20171$0.18$0.18$0.18
(Data provided by Zacks Investment Research)

Dividends

Dividend History for BioTelemetry (NASDAQ:BEAT)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for BioTelemetry (NASDAQ:BEAT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/9/2014Ronald AhrensDirectorBuy6,000$7.37$44,220.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2013Ronald AhrensDirectorBuy5,000$11.73$58,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2012Ronald A AhrensDirectorBuy15,000$2.22$33,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/5/2012Joseph H CapperCEOBuy23,540$2.25$52,965.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/31/2012Joseph H CapperCEOBuy2,600$2.28$5,928.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/29/2012Joseph H CapperCEOBuy10,800$2.30$24,840.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/28/2012Joseph H CapperCEOBuy1,300$2.19$2,847.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2012Joseph H CapperCEOBuy1,600$2.12$3,392.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/23/2012Joseph H CapperCEOBuy9,600$2.08$19,968.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/20/2012Joseph H CapperCEOBuy14,160$1.97$27,895.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/17/2012Joseph H CapperCEOBuy9,800$2.10$20,580.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for BioTelemetry (NASDAQ:BEAT)
DateHeadline
07/26/16 02:41 PMBioTelemetry, Inc. Announces FDA Approval of Its Next Generation Device, the MCOT™ Patch - GlobeNewswire (press release)
07/26/16 10:27 AMBioTelemetry, Inc. Announces FDA Approval of Its Next Generation Device, the MCOT™ Patch
07/26/16 09:03 AMBioTelemetry Gets FDA Clearance For Its MCOT Patch -
07/24/16 07:30 AMIs $19 Price Target Attainable For BioTelemetry, Inc. (NASDAQ:BEAT)? - Investor Newswire
07/23/16 07:00 AMBioTelemetry Inc. (BEAT) Hits New 52-week High During July 21 Session - Equities.com
07/22/16 10:58 AMBioTelemetry, Inc. (BEAT) Sees New 52-Week High - Finance Daily
07/22/16 10:58 AMBioTelemetry Inc (NASDAQ:BEAT) Stock Technicals Hit Strength - CML News
07/21/16 02:49 PMBioTelemetry (BEAT) Announces Consent Judgment on InfoBionic
07/21/16 11:17 AMIs Buying BioTelemetry, Inc. Here a Winning Strategy? The Stock Just Gapped Up - Consumer Eagle
07/20/16 03:17 PMCould BioTelemetry, Inc. Change Direction After Today's Huge Increase? - Consumer Eagle
07/20/16 03:17 PMShares Jumping Higher in Session: BioTelemetry, Inc. (NASDAQ:BEAT) - TGP
07/20/16 03:17 PMBioTelemetry, Inc. Announces Its Latest Success in Patent Enforcement - GlobeNewswire (press release)
07/20/16 10:51 AMBioTelemetry, Inc. Announces Its Latest Success in Patent Enforcement
07/18/16 02:51 PMShare Performance Summary for: BioTelemetry, Inc. (NASDAQ:BEAT) - Press Telegraph
07/17/16 07:30 AMNext Weeks Broker Price Targets For BioTelemetry, Inc. (NASDAQ:BEAT) - Fiscal Standard
07/16/16 02:46 PMStrong Sell Calls For BioTelemetry, Inc. (NASDAQ:BEAT) At 0 - Investor Newswire
07/15/16 07:04 PMBioTelemetry Inc. (BEAT) Hits New 52-week High During July 13 Session - Equities.com
07/14/16 02:51 PMBioTelemetry, Inc. (BEAT) Reached a 52-Week High - Finance Daily
07/14/16 02:51 PMBioTelemetry Inc. (BEAT) Hits New 52-week High During July 12 Session - Equities.com
07/13/16 02:49 PMBioTelemetry, Inc. (BEAT) Reaches New 52-Week High - Finance Daily
07/13/16 02:49 PMA Reversal for BioTelemetry, Inc. Is Not Near. The Stock Reaches 52-Week High Today - Press Telegraph
07/12/16 08:17 PMShares Ascending to a Recent High: BioTelemetry, Inc. (NASDAQ:BEAT) - Press Telegraph
07/12/16 02:53 PMWill BioTelemetry, Inc. (NASDAQ:BEAT) Surprise This Quarter? - Investor Newswire
07/12/16 04:43 AMBioTelemetry Inc. (BEAT) Jumps 5.8% on July 11 - Equities.com
07/11/16 02:46 PMBioTelemetry, Inc. versus Cross Country Healthcare, Inc. Head to Head Compare - CML News
07/10/16 02:43 PMIs $19 Within Reach For BioTelemetry, Inc. (NASDAQ:BEAT)? - Investor Newswire
07/07/16 02:47 PMAddus HomeCare Corporation versus BioTelemetry, Inc. Head to Head Compare - CML News
07/06/16 07:35 AMStock Tracking Down This Month; Investor Alert on BioTelemetry, Inc. (NASDAQ:BEAT) - Engelwood Daily
07/04/16 02:43 PMShare Performance Recap for: BioTelemetry, Inc. (NASDAQ:BEAT) - Press Telegraph
07/02/16 02:50 PMBioTelemetry, Inc. (NASDAQ:BEAT) Expected to Reach Highs Of $19 - Investor Newswire
07/02/16 10:29 AMEarnings Surprise in Focus: BioTelemetry, Inc. (NASDAQ:BEAT) - Investor Newswire
07/01/16 07:34 AMICON (ICLR) Set to Acquire Clinical Research Management -
06/30/16 02:59 PMBioTelemetry, Inc. Stock Momentum Hits Strength - CML News
06/30/16 02:59 PMBioTelemetry, Inc. Just Recorded A Sigfniciant Decline - Press Telegraph
06/29/16 10:59 AMRecently Issued Stock Ratings For BioTelemetry, Inc. (NASDAQ:BEAT) - Fiscal Standard
06/28/16 07:15 AMBioTelemetry, Inc. breached its 50 day moving average in a Bearish Manner : BEAT-US : June 28, 2016 -
06/27/16 02:26 PMBioTelemetry, Inc. (NASDAQ:BEAT) Broker Price Targets For The Coming Week - Fiscal Standard
06/25/16 02:46 PMStrong Sell Calls Recommendations For BioTelemetry, Inc. (NASDAQ:BEAT) At 0 - Investor Newswire
06/24/16 07:56 PMBioTelemetry, Inc. versus BioScrip, Inc. Head to Head Compare - CML News
06/22/16 07:55 PMNew Broker Ratings For BioTelemetry, Inc. (NASDAQ:BEAT) - FTSE News
06/21/16 07:32 AMBioTelemetry, Inc. (NASDAQ:BEAT) Current Analyst Ratings - Fiscal Standard
06/20/16 10:07 AMGap-up Opens Just Aren't What They Used to Be -
06/19/16 02:41 PMThis Weeks Broker Views For BioTelemetry, Inc. (NASDAQ:BEAT) - Fiscal Standard
06/19/16 07:28 AMStrong Buy Calls Count For BioTelemetry, Inc. (NASDAQ:BEAT) At 1 - Investor Newswire
06/12/16 11:00 AM5 Trade Ideas for Monday: BioTelemetry, CBOE, Honeywell, Intuitive Surgical and Mastercard -
06/09/16 11:43 AMNewly released market study: CardioNet, Inc. (BEAT) - Financial and Strategic SWOT Analysis Review
06/03/16 11:21 AMBioTelemetry, Inc. (NASDAQ:BEAT) Do Brokers Advise Buy, Sell Or Hold? - Share Trading News
06/01/16 02:52 PMBioTelemetry, Inc. (BEAT) Hits a New 52-Week High - Finance Daily - BioTelemetry, Inc. (BEAT) Hits a New 52-Week HighFinance DailyThe stock of BioTelemetry, Inc. (NASDAQ:BEAT) exerienced a new one year high price at $17.68 on Tuesday. The stock closed up 1.70% ending the day at $17.35. Volume came in at 657,930 and the stock hit a low of $17.04 during the day. Company shares ...
06/01/16 11:19 AMBuy, Sell Or Hold Rating For BioTelemetry, Inc. (NASDAQ:BEAT)? - Share Trading News - Buy, Sell Or Hold Rating For BioTelemetry, Inc. (NASDAQ:BEAT)?Share Trading NewsBioTelemetry, Inc. has a 50 day moving average of 14.43 and a 200 day moving average of 12.29. The stock's market capitalization is 485.91M, it has a 52-week low of 8.74 and a 52-week high of 17.68. The share price of the company (NASDAQ:BEAT) was ...Stock Trending Up: BioTelemetry, Inc. (NASDAQ:BEAT)The Postall 2 news articles »
05/31/16 08:31 PMShares Touching a Recent High: BioTelemetry, Inc. (NASDAQ:BEAT) - HNN - Shares Touching a Recent High: BioTelemetry, Inc. (NASDAQ:BEAT)HNNBioTelemetry, Inc. (NASDAQ:BEAT)'s stock has seen a steady move upward, reaching $17.56 on a recent bid, generating strong interest amongst investors and analysts alike. Shareholders are noting a Return on Investment (ROI) of 9.10%. Return on ...and more »

Social

About BioTelemetry

BioTelemetry logoBioTelemetry, Inc. (BioTelemetry), formerly CardioNet, Inc., provides cardiac monitoring services, cardiac monitoring device manufacturing, and centralized cardiac core laboratory services. The Company operates in three segments: patient services, product and research services. The patient services business segment's principal focus is on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders, through its core Mobile Cardiac Outpatient Telemetry(MCOT), event and Holter services in a healthcare setting. The product business segment focuses on the development, manufacturing, testing and marketing of medical devices to medical companies, clinics and hospitals. The Company's research services focuses on providing cardiac safety monitoring services for drug and medical treatment trials in a research environment. In August 2012, the Company completed the acquisition of Cardiocore Lab, Inc. (Cardiocore).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: BEAT
  • CUSIP:
Key Metrics:
  • Previous Close: $17.34
  • 50 Day Moving Average: $16.64
  • 200 Day Moving Average: $13.55
  • P/E Ratio: 47.37
  • P/E Growth: 0.00
  • Market Cap: $521.90M
  • Beta: 1.1
  • Current Year EPS Consensus Estimate: $0.69 EPS
  • Next Year EPS Consensus Estimate: $0.76 EPS
Additional Links:
BioTelemetry (NASDAQ:BEAT) Chart for Tuesday, July, 26, 2016